Flecainide + Bupropion Hydrobromide Interaction
Moderateinteraction on record
Description
CYP2D6 substrate Type 1C antiarrhythmic. Bupropion inhibits CYP2D6 and can increase flecainide concentrations. Consider dose reduction of flecainide when used with bupropion.
Mechanism
CYP2D6 inhibition
Source: NLP:bupropion hydrobromide